Plexus Corp. (NASDAQ:PLXS – Get Free Report) has been assigned an average recommendation of “Hold” from the five research firms that are presently  covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to  the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $159.00. 
A number of equities research analysts have recently issued reports on PLXS shares. Stifel Nicolaus set a $150.00 price objective on Plexus in a research note on Friday, October 24th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Plexus in a research note on Wednesday, October 8th. Williams Trading set a $165.00 price objective on Plexus in a research note on Monday, September 22nd. Benchmark reiterated a “buy” rating and set a $165.00 price objective on shares of Plexus in a research note on Friday, October 24th. Finally, Wall Street Zen cut Plexus from a “strong-buy” rating to a “buy” rating in a research note on Sunday, October 19th.
Check Out Our Latest Research Report on Plexus
Insider Transactions at Plexus
Hedge Funds Weigh In On Plexus
Several institutional investors and hedge funds have recently modified their holdings of PLXS. Salomon & Ludwin LLC bought a new position in Plexus during the 3rd quarter worth $30,000. Huntington National Bank lifted its holdings in shares of Plexus by 41.5% during the second quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after buying an additional 95 shares in the last quarter. TD Private Client Wealth LLC lifted its holdings in shares of Plexus by 185.6% during the first quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company’s stock worth $66,000 after buying an additional 334 shares in the last quarter. CWM LLC lifted its holdings in shares of Plexus by 65.7% during the second quarter. CWM LLC now owns 537 shares of the technology company’s stock worth $73,000 after buying an additional 213 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Plexus by 583.3% during the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock worth $78,000 after buying an additional 490 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors and hedge funds.
Plexus Trading Down 0.8%
NASDAQ:PLXS opened at $139.90 on Friday. Plexus has a twelve month low of $103.43 and a twelve month high of $172.89. The company has a quick ratio of 0.77, a current ratio of 1.58 and a debt-to-equity ratio of 0.06. The business has a 50 day moving average price of $142.02 and a two-hundred day moving average price of $134.78. The company has a market cap of $3.78 billion, a P/E ratio of 22.35 and a beta of 0.80.
Plexus (NASDAQ:PLXS – Get Free Report) last announced its quarterly earnings data on Wednesday, October 22nd. The technology company reported $2.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.30. Plexus had a return on equity of 12.77% and a net margin of 4.29%.The company had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the prior year, the business posted $1.85 EPS. The business’s revenue was up .7% compared to the same quarter last year. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS. As a group, analysts expect that Plexus will post 5.9 EPS for the current fiscal year.
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Further Reading
- Five stocks we like better than Plexus
 - How to Invest in Blue Chip Stocks
 - Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No
 - With Risk Tolerance, One Size Does Not Fit All
 - ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
 - The Top 3 Healthcare Dividend Stocks to Buy and Hold
 - Super Micro’s Moment of Truth: A Growth Story Under Pressure
 
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
